Enveric Biosciences, Inc. (ENVB) › Total AssetsEnveric Biosciences, Inc. (ENVB) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $1.1K2011: $22.4K2012: $5.6K2013: $4.5K2014: $5.1K2015: $13.83M2016: $39.51M2017: $52.20M2018: $29.64M2019: $108.8K2020: $4.10M2021: $26.72M2022: $19.55M2023: $4.30M2024: $3.08M2025: $5.10M$5.10M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$5.10M+65.3%2024$3.08M-28.3%2023$4.30M-78.0%2022$19.55M-26.8%2021$26.72M+552.2%2020$4.10M+3665.9%2019$108.8K-99.6%2018$29.64M-43.2%2017$52.20M+32.1%2016$39.51M+185.6%2015$13.83M+271973.4%2014$5.1K+13.8%2013$4.5K-20.2%2012$5.6K-75.1%2011$22.4K+1893.8%2010$1.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share